(SUPN) Supernus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Supernus Pharmaceuticals | (SUPN) share price targets
Complete technical analysis of Supernus Pharmaceuticals (SUPN) by charts plus indicators, forecast predictions and share price targets for Supernus Pharmaceuticals (SUPN)
Supernus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-04-05 View latest technical analysis
10 day averaged volume of Supernus Pharmaceuticals is 390080
Date | Daily Closing Price | Open | High | Low | Volume |
05 Fri Apr 2024 | 33.55 | 33.33 | 33.60 | 33.13 | 0.623 times |
04 Thu Apr 2024 | 33.24 | 34.44 | 34.49 | 33.09 | 0.743 times |
03 Wed Apr 2024 | 33.85 | 32.85 | 34.07 | 32.82 | 0.793 times |
02 Tue Apr 2024 | 33.17 | 33.23 | 33.61 | 32.77 | 0.779 times |
01 Mon Apr 2024 | 33.52 | 34.10 | 34.10 | 33.06 | 0.605 times |
28 Thu Mar 2024 | 34.11 | 33.84 | 34.39 | 33.47 | 1.259 times |
27 Wed Mar 2024 | 33.74 | 32.85 | 33.83 | 32.56 | 0.933 times |
26 Tue Mar 2024 | 32.48 | 32.99 | 33.59 | 32.29 | 1.568 times |
25 Mon Mar 2024 | 32.75 | 34.73 | 34.98 | 32.57 | 0.94 times |
22 Fri Mar 2024 | 34.52 | 35.15 | 35.22 | 33.97 | 1.263 times |
My analysis of stock is bearish for shortterm, and stock might move down till 32.6 or till 31.4. Use a stoploss of 33.59 and if the stock hits stoploss, then it can shoot up till 34.59
Share price targets for Supernus Pharmaceuticals (SUPN)
Target Type | Value |
Downside Target | 26.13 |
Downside Target | 29.78 |
Downside Target | 30.88 |
Downside Target | 32.00 |
Downside Target | 32.77 |
Upside Target | 34.49 |
Upside Target | 34.83 |
Upside Target | 34.98 |
Upside Target | 35.44 |
Intraday share price targets for Supernus Pharmaceuticals (SUPN)
Target Type | Value |
Downside Intraday Target | 32.72 |
Downside Intraday Target | 31.88 |
Upside Intraday Target | 34.44 |
Upside Intraday Target | 35.32 |
Upside Intraday Target | 33.6 |
Weekly technical analysis of Supernus Pharmaceuticals (SUPN)
Date | Weekly Closing Price | Open | High | Low | Volume |
05 Fri Apr 2024 | 33.55 | 34.10 | 34.49 | 32.77 | 0.754 times |
28 Thu Mar 2024 | 34.11 | 34.73 | 34.98 | 32.29 | 0.711 times |
22 Fri Mar 2024 | 34.52 | 33.15 | 35.44 | 32.55 | 0.918 times |
15 Fri Mar 2024 | 32.98 | 31.16 | 34.83 | 30.88 | 1.476 times |
08 Fri Mar 2024 | 31.07 | 30.96 | 32.00 | 29.78 | 0.57 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Supernus Pharmaceuticals (SUPN)
Date | Monthly Closing Price | Open | High | Low | Volume |
05 Fri Apr 2024 | 33.55 | 34.10 | 34.49 | 32.77 | 0.144 times |
28 Thu Mar 2024 | 34.11 | 30.00 | 35.44 | 29.78 | 1.336 times |
29 Thu Feb 2024 | 29.70 | 27.80 | 32.30 | 26.27 | 0.992 times |
31 Wed Jan 2024 | 27.68 | 28.85 | 29.99 | 26.47 | 0.921 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Supernus Pharmaceuticals (SUPN)
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term but the sell signal is initial and weak.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Supernus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 33.48 and Supernus Pharmaceuticals (SUPN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Supernus Pharmaceuticals (SUPN) stock. Volume based technical analysis of Supernus Pharmaceuticals (SUPN) stock is negative.
Supernus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Supernus Pharmaceuticals ( (SUPN) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Supernus Pharmaceuticals in short term but the sell signal is initial and weak.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Supernus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 33.48 and Supernus Pharmaceuticals (SUPN) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Supernus Pharmaceuticals (SUPN) stock. Volume based technical analysis of Supernus Pharmaceuticals (SUPN) stock is negative.
Supernus Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.